KCT0000043招募中未知
Effect of Intraoperative Periarticular Multimodal Drug Injection in Total Knee Arthroplasty - A Prospective, Randomized, Double Blind Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 228
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 55(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •Degenerative arthritis patients
- •Both male and female
排除标准
- •Patients who has major psychiatric problem, Patients who previously had strong dependency to pain killers, Patient who has an allergy to at least one component of the mixture, Patients who has kidney or liver function problem prior to the surgery, Patients who has major cardiovascular disease
研究者
相似试验
已完成
3 期
Result of Pre-emptive periarticular multimodal drug injection for postoperative pain management in simultaneous bilateral TKAPatients who had knee pain with diagnosis of osteoarthritis and were scheduled for simultaneous bilateral TKA.simultaneous bilateral TKA,periarticular multimodal drugs injection,pre-emptiveTCTR20170617001one45
招募中
4 期
Comparative efficacy study of periarticular multimodal analgesic injection containing corticosteroid o rnonsteroidal anti-inflammatory drugs in total knee arthroplasty; randomized control trialPost-operation pain in total knee replacement (primary osteoarthritis)Total knee arthroplasty,periarticular injection in total knee replacement,morphine consumption,triamcinolone acetonide,ketorolac,TCTR20191221006none52
已完成
不适用
Investigation of the Efficacy of Intra-articular Prolotherapy on the Primary Osteoarthritis of Knee: Patients’ Level of Pain and Knee Joint’s Range of Motioknee osteoarthritis.IRCT2013092210336N4Vice chancellor for research, Iran University of Medical Sciences70
尚未招募
2 期
Effect of PRP derived from umbilical cord blood in the treatment of knee arthritisOsteoarthritis of kneeIRCT20211102052944N2Royan Stem Cell Technology Company30
进行中（未招募）
不适用
Efficacy and safety of intra-articular multiple doses of 500 µg icatibant including 40 mg triamcinolone as calibrator in a randomized, double-blind, parallel-group, placebo-controlled 13-week multi-centre study in patients with symptomatic knee osteoarthritis**After the clinical start of the study, an extension of the follow-up period has been established by amendment n°2, extending the observation period by further 26 weeks; thus, the overall study duration will become totally 39 weeks. - TRICAPSubjects with painful osteoarthritis in the kneeEUCTR2005-003258-87-DESanofi Aventis Deutschland GmbH550